Antenatal screening for chromosomal and genetic abnormalities: Cost effectiveness and outcome

Antenatal screening for chromosomal and genetic abnormalities: Cost effectiveness and outcome


چاپ صفحه
پژوهان
صفحه نخست سامانه
چکیده مقاله
چکیده مقاله
نویسندگان
نویسندگان
دانلود مقاله
دانلود مقاله
دانشگاه علوم پزشکی تبریز
دانشگاه علوم پزشکی تبریز

نویسندگان: سیمین تقوی , حسین علیخواه , فرشته فرهادی , محمد نقوی بهزاد , رضا پیری

کلمات کلیدی: Antenatal Screening, Congenital Abnormalities, Cost Effectiveness, Evidence-Based Practice, Clinical Decision Making

نشریه: 0 , 3 , 6 , 2018

اطلاعات کلی مقاله
hide/show

نویسنده ثبت کننده مقاله محمد نقوی بهزاد
مرحله جاری مقاله تایید نهایی
دانشکده/مرکز مربوطه کمیته تحقیقات دانشجویی
کد مقاله 63938
عنوان فارسی مقاله Antenatal screening for chromosomal and genetic abnormalities: Cost effectiveness and outcome
عنوان لاتین مقاله Antenatal screening for chromosomal and genetic abnormalities: Cost effectiveness and outcome
ناشر 8
آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ بلی
عنوان نشریه (خارج از لیست فوق) Journal of Analytical Research in Clinical Medicine
نوع مقاله Original Article
نحوه ایندکس شدن مقاله ایندکس شده سطح چهار – Index Medicus
آدرس لینک مقاله/ همایش در شبکه اینترنت

خلاصه مقاله
hide/show

As an essential part of antenatal care, pregnant women of all ages should be offered screening for chromosomal abnormalities before 20 weeks of gestation. This study was aimed to evaluate the type and frequency of chromosomal abnormalities following pregnancy screening tests, so that we can compare the actual pregnancy outcomes with test results, helping us in practical decision making. A cross-sectional study was conducted on 557 pregnant patients, presenting for prenatal diagnostic amniocentesis for chromosomal abnormalities, to Al-Zahra hospital, Tabriz, Iran, since 2012 to 2015. Amniocentesis was conducted by an expert obstetrician at second trimester between 16 and 22 weeks of gestation. An interview was set for pregnancy outcomes to assess the test results. Of 557 cases, the mean maternal age in amniocentesis was 31.84 ± 6.92 years (range: 15-47 years). Amniocentesis revealed the presence of chromosomal abnormalities in 32 cases (5.7%). The most common diagnosed chromosomal abnormality was Down syndrome (50.0%) followed by other chromosomal abnormalities. Following up the patients, 92.4% of newborns did not have any congenital abnormality, but the remaining (7.6%) had both chromosomal and non-chromosomal abnormalities. No fetal loss was reported in this study. Assessment of total costs revealed that $US100 had been spent for hospitalization, and about $US500 for genetic tests. There is still no consensus on the most cost-effective strategy that should be implemented to diagnose chromosomal anomalies. Therefore, we did not have an actual gold standard to compare with amniocentesis. More studies analyzing natural outcome after prenatal diagnosis of these chromosomal abnormalities are needed.

نویسندگان
hide/show

نویسنده نفر چندم مقاله
سیمین تقویاول
حسین علیخواهدوم
فرشته فرهادیچهارم
محمد نقوی بهزادپنجم
رضا پیریهشتم

لینک دانلود مقاله
hide/show

نام فایل تاریخ درج فایل اندازه فایل دانلود
JARCM-6-108.pdf1397/06/28887840دانلود
Tasvib.jpg1397/06/281298238دانلود